Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-25-001326
Filing Date
2025-08-13
Accepted
2025-08-13 16:39:52
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q g084912_10q.htm   iXBRL 10-Q 1380267
2 EXHIBIT 3.4 g084912_ex3-4.htm EX-3.4 9049
3 EXHIBIT 31.1 g084912_ex31-1.htm EX-31.1 11011
4 EXHIBIT 31.2 g084912_ex31-2.htm EX-31.2 11009
5 EXHIBIT 32.1 g084912_ex32-1.htm EX-32.1 6524
6 EXHIBIT 32.2 g084912_ex32-2.htm EX-32.2 6481
7 GRAPHIC img003_v3.jpg GRAPHIC 26389
8 GRAPHIC img004_v3.jpg GRAPHIC 25166
9 GRAPHIC img001_v1.jpg GRAPHIC 48379
10 GRAPHIC img002_v1.jpg GRAPHIC 48084
11 GRAPHIC img001_v5.jpg GRAPHIC 244828
12 GRAPHIC img002_v5.jpg GRAPHIC 344582
13 GRAPHIC img003_v5.jpg GRAPHIC 95615
14 GRAPHIC img004_v5.jpg GRAPHIC 49456
  Complete submission text file 0001753926-25-001326.txt   7459919

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE pths-20250630.xsd EX-101.SCH 46635
16 XBRL CALCULATION FILE pths-20250630_cal.xml EX-101.CAL 32963
17 XBRL DEFINITION FILE pths-20250630_def.xml EX-101.DEF 154575
18 XBRL LABEL FILE pths-20250630_lab.xml EX-101.LAB 409586
19 XBRL PRESENTATION FILE pths-20250630_pre.xml EX-101.PRE 280410
65 EXTRACTED XBRL INSTANCE DOCUMENT g084912_10q_htm.xml XML 990598
Mailing Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 919-908-2422
Pelthos Therapeutics Inc. (Filer) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41964 | Film No.: 251212325
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)